General Information of Drug (ID: DMFU6OD)

Drug Name
Quinazoline derivative 13 Drug Info
Synonyms PMID26936077-Compound-24
Indication
Disease Entry ICD 11 Status REF
Arteriosclerosis BD40 Patented [1]
Atopic dermatitis EA80 Patented [1]
Gastrointestinal disease DE2Z Patented [1]
Multiple sclerosis 8A40 Patented [1]
Cross-matching ID
PubChem CID
60161489
TTD Drug ID
DMFU6OD

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
MEDI0618 DM7GNSY Osteoarthritis pain MG30.31 Phase 1 [2]
Imidazopyridazine derivative 8 DMF7NXJ Inflammation 1A00-CA43.1 Patented [1]
Piperazine urea derivative 4 DM3K7IM Inflammation 1A00-CA43.1 Patented [1]
Piperidine derivative 2 DMHXMB4 Inflammation 1A00-CA43.1 Patented [1]
Benzimidazole derivative 10 DML3PE4 N. A. N. A. Patented [1]
Benzothiazine-carboxamide compound 2 DMMP2RT Skin inflammation EF20.Y Patented [1]
Peptide analog 71 DMSEKZG N. A. N. A. Patented [1]
Amidine compound 3 DMV0QJ4 Inflammation 1A00-CA43.1 Patented [1]
Benzothiazine-carboxamide compound 4 DMSR918 Skin inflammation EF20.Y Patented [1]
Quinazoline derivative 11 DMAH435 Chronic obstructive pulmonary disease CA22 Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Proteinase activated receptor 2 (PAR2) TTQR74A PAR2_HUMAN Antagonist [1]

References

1 Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Expert Opin Ther Pat. 2016;26(4):471-83.
2 Clinical pipeline report, company report or official report of AstraZeneca